Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients:: results from the Swedish Trial in Old Patients with Hypertension -: 2

被引:136
作者
Lindholm, LH [1 ]
Hansson, L
Ekbom, T
Dahlöf, B
Lanke, J
Linjer, E
Scherstén, B
Wester, PO
Hedner, T
de Faire, U
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Social Sci, Uppsala, Sweden
[3] Univ Lund, Malmo Univ Hosp, Dept Community Med, Malmo, Sweden
[4] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden
[5] Univ Lund, Dept Stat, Lund, Sweden
[6] Univ Lund, Dalby Lund, Dept Community Hlth Sci, Lund, Sweden
[7] Sahlgrens Univ Hosp, Dept Clin Pharmacol, S-41345 Gothenburg, Sweden
[8] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden
关键词
hypertension; diabetes; elderly; drug treatment; randomized controlled trial;
D O I
10.1097/00004872-200018110-00020
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background The benefits of treating hypertension in elderly diabetic patients, in terms of achieving reductions in cardiovascular morbidity and mortality, have been documented in several recent prospective trials. There has, however, been some controversy regarding the effect of different antihypertensive drugs on the frequency of myocardial infarction in this group of patients. Design STOP Hypertension-5 was a prospective, randomized, open trial with blinded endpoint evaluation. Methods We studied 6614 elderly patients aged 70-84 years; 719 of them had diabetes mellitus at the start of the study (mean age 75.8 years). Patients were randomly assigned to one of three treatment strategies: conventional antihypertensive drugs (diuretics or beta -blockers), calcium antagonists, or angiotensin converting enzyme (ACE) inhibitors. Results Reduction in blood pressure was similar in the three treatment groups of diabetics. The prevention of cardiovascular mortality was also similar; the frequency of this primary endpoint did not differ significantly between the three groups. There were, however, significantly fewer (P = 0.025) myocardial infarctions during ACE inhibitor treatment (n = 17) than during calcium antagonist treatment (n = 32; relative risk 0.51, 95% confidence interval 0.28-0.92); but a (non-significant) tendency to more strokes during ACE inhibitor treatment (n = 34 compared with n = 29; relative risk 1.16, 95%, confidence interval 0.71-1.91). Conclusion Treatment of hypertensive diabetic patients with conventional antihypertensive drugs (diuretics, beta -blockers, or both) seemed to be as effective as treatment with newer drugs such as calcium antagonists or ACE inhibitors. J Hypertens 18:1671-1675 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1671 / 1675
页数:5
相关论文
共 12 条
[1]  
[Anonymous], 1980, TECHN REP SER WHO
[2]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[3]  
CURD JD, 1996, JAMA-J AM MED ASSOC, V276, P1886
[4]  
Dahlof B, 1993, Blood Press, V2, P136, DOI 10.3109/08037059309077541
[5]   The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension [J].
Estacio, RO ;
Jeffers, BW ;
Hiatt, WR ;
Biggerstaff, SL ;
Gifford, N ;
Schrier, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :645-652
[6]  
Gerstein HC, 2000, LANCET, V355, P253
[7]   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].
Hansson, L ;
Lindholm, LH ;
Niskanen, L ;
Lanke, J ;
Hedner, T ;
Niklason, A ;
Luomanmäki, K ;
Dahlöf, B ;
de Faire, U ;
Mörlin, C ;
Karlberg, BE ;
Wester, PO ;
Björck, JE .
LANCET, 1999, 353 (9153) :611-616
[8]   Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].
Hansson, L ;
Lindholm, LH ;
Ekbom, T ;
Dahlöf, B ;
Lanke, J ;
Scherstén, B ;
Wester, PO ;
Hedner, T ;
de Faire, U .
LANCET, 1999, 354 (9192) :1751-1756
[9]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[10]  
Stearne MR, 1998, BRIT MED J, V317, P713